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Abstract
Background: The number of Mendelian randomization analyses including large numbers
of genetic variants is rapidly increasing. This is due to the proliferation of genome-wide
association studies, and the desire to obtain more precise estimates of causal effects.
However, some genetic variants may not be valid instrumental variables, in particular
due to them having more than one proximal phenotypic correlate (pleiotropy).
Methods: We view Mendelian randomization with multiple instruments as a meta-ana-
lysis, and show that bias caused by pleiotropy can be regarded as analogous to small
study bias. Causal estimates using each instrument can be displayed visually by a funnel
plot to assess potential asymmetry. Egger regression, a tool to detect small study bias in
meta-analysis, can be adapted to test for bias from pleiotropy, and the slope coefficient
from Egger regression provides an estimate of the causal effect. Under the assumption
that the association of each genetic variant with the exposure is independent of the pleio-
tropic effect of the variant (not via the exposure), Egger’s test gives a valid test of the null
causal hypothesis and a consistent causal effect estimate even when all the genetic vari-
ants are invalid instrumental variables.
Results: We illustrate the use of this approach by re-analysing two published Mendelian
randomization studies of the causal effect of height on lung function, and the causal ef-
fect of blood pressure on coronary artery disease risk. The conservative nature of this ap-
proach is illustrated with these examples.
Conclusions: An adaption of Egger regression (which we call MR-Egger) can detect some
violations of the standard instrumental variable assumptions, and provide an effect esti-
mate which is not subject to these violations. The approach provides a sensitivity ana-
lysis for the robustness of the findings from a Mendelian randomization investigation.
VC The Author 2015; Published by Oxford University Press on behalf of the International Epidemiological Association. 512
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
International Journal of Epidemiology, 2015, 512–525
doi: 10.1093/ije/dyv080
Advance Access Publication Date: 6 June 2015
Original Article
 at U
niversity Library on Septem
ber 14, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
Key words: Mendelian randomization, invalid instruments, meta-analysis, pleiotropy, small study bias, MR-Egger
test
Introduction
Mendelian randomization1 is becoming an established
method for testing whether a modifiable exposure has a
causal role in the aetiology of a disease.2,3 As the subject
moves forward, ever more ambitious analyses are being
attempted. In particular, due to the proliferation of genome-
wide association studies, the number of Mendelian random-
ization analyses using a large number of genetic variants is
rapidly increasing.4,5 If the variants in total explain a larger
proportion of the variance in the exposure, this will lead to
more precise estimates of causal effects, thus increasing the
power for testing causal hypotheses.6,7 However, an
enlarged set of genetic variants is more likely to contain in-
valid instrument variables (IVs), due to violations of the as-
sumptions necessary for valid causal inference. The issue of
horizontal pleiotropy—where a genetic variant affects the
outcome via a different biological pathway from the expos-
ure under investigation—is a particular concern.1,3,8 The in-
clusion of pleiotropic variants in a Mendelian
randomization analysis can lead to biased causal effect esti-
mates and increased type I error rates for testing the causal
null hypothesis.9 If the instrumental variable assumptions
are violated, the findings of a Mendelian randomization
analysis are open to the same criticisms as those levelled at
traditional observational epidemiological analyses.10
In this paper, we view Mendelian randomization of a
single study with multiple IVs as analogous to a meta-
analysis. The overall causal estimate based on all the IVs
can be interpreted as a weighted average of the individual
IV estimates, just like a meta-analysis of separate study
results. We show that bias resulting from pleiotropy is
analogous to small study bias in meta-analysis,11 where
small studies (with less precise estimates) tend to report
larger estimates than big studies (with more precise esti-
mates). One reason for this is that estimates from small
studies with null findings tend not to be published. This in-
duces a negative correlation across studies between the mag-
nitude and precision of estimates. Publication bias is one
aspect of the wider issue of dissemination bias.12 Moreover,
there may be a host of complex, context-specific reasons
that lead to differences between results from small and large
studies in a specific meta-analysis. The general phenomenon
is therefore prudently referred to under the umbrella term of
‘small study’ bias.11,13,14 In the context of Mendelian ran-
domization with multiple instruments, we equate the preci-
sion of a single study’s estimate with the strength of a single
instrument. Under certain assumptions, applying the regres-
sion method underlying Egger’s test—a method for assessing
small study bias in meta-analysis11,13–15—is shown to give a
consistent causal effect estimate even when all the genetic
variants violate the standard IV assumptions.
In this paper, we describe a general statistical model for
Mendelian randomization data with multiple potentially
invalid instruments. Using the graphical representations of
a scatter plot and a funnel plot, we discuss why the stand-
ard method of estimation, two-stage least squares (TSLS),
may be biased when pleiotropy is present and when Egger
regression can provide a consistent estimate of the causal
effect. We apply both methods to data available from two
published Mendelian randomization studies, and explore
their performance further using simulated data. Finally, we
emphasize that the method advanced here can strengthen
or weaken evidence for a causal effect but, as for any single
Mendelian randomization method, is itself subject to as-
sumptions and limitations.
Methods
We consider data from a Mendelian randomization study
on N participants. For each participant, indexed by i, we
Key Messages
• Mendelian randomization analyses using multiple genetic variants can be viewed as a meta-analysis of the causal es-
timates from each variant.
• If the genetic variants have pleiotropic effects on the outcome, these causal estimates will be biased.
• Funnel plots offer a simple way to detect directional pleiotropy; that is, whether causal estimates from weaker vari-
ants tend to be skewed in one direction.
• Under a weaker set of assumptions than typically used in Mendelian randomization, an adaption of Egger regression
(MR-Egger) can be used to detect and correct for the bias due to directional pleiotropy.
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measure J genetic variants (Gi1;Gi2; . . . ;GiJ), a modifiable
exposure, (Xi) and an outcome (Yi). We assume that
confounders (represented by a single variable Ui) are un-
known. The genetic variants are assumed to take the values
0, 1 or 2 (representing the number of exposure-increasing
alleles of a bi-allelic single nucleotide polymorphism). The
exposure is taken as a linear function of the genetic vari-
ants, the confounders and an independent error term (Xi ).
The coefficients cj for each variant j represent the effects of
the genetic variants on the exposure. The outcome is taken
as a linear function of the genetic variants, the exposure,
the confounders and an independent error term (Yi ). The
causal effect of the exposure on the outcome is b. The coef-
ficients aj for each variant j represent the direct effects of
the genetic variants on the outcome that are not mediated
by the exposure. The total effect of each variant on the out-
come comprises the direct effect (aj) and the indirect effect
via the exposure (bcj).
Xi ¼
XJ
j¼1
cjGij þUi þ Xi (1)
Yi ¼
XJ
j¼1
ajGij þ bXi þUi þ Yi : (2)
Although the effects of the confounders on the exposure and
on the outcome are taken as equal in equations (1) and (2),
this assumption is not necessary and further parameters for
these effects could be introduced into the model without af-
fecting the methodological developments in this paper.
A genetic variant is a valid instrumental variable if the
following assumptions hold:
• IV1: The genetic variant is independent of confounders
U;
• IV2: The genetic variant is associated with the exposure
X;
• IV3: The genetic variant is independent of the outcome Y
conditional on the exposure X and confounders U.
The second assumption implies that cj 6¼ 0 in equation
(1). The third assumption is also referred to as ‘exclusion re-
striction’, and implies that aj¼ 0 in equation (2); that is, an
IV does not have an effect on the outcome when the
exposure remains fixed.16 The IV assumptions and coeffi-
cients from equations (1) and (2) are represented in Figure 1.
Mendelian randomization and meta-analysis
With a single genetic variant j, the causal effect of the expos-
ure on the outcome can be estimated using the ratio method
(or Wald method17) as the coefficient from regression of the
outcome on the genetic variant (denoted by C^j) divided by
the coefficient from regression of the exposure on the vari-
ant (denoted c^j).
18 The reduced-form equation relating the
outcome to the genetic variant j can be written as:
Yi ¼ CjGij þ 0Yij
¼ ðaj þ bcjÞGij þ 0Yij :
If the genetic variant is a valid IV, aj ¼ 0 and the ratio
method estimand (the quantity that is being estimated,
denoted by bj) is
Cj
cj
¼ bcjcj ¼ b.
With multiple genetic variants, the causal effect of the
exposure on the outcome can be estimated using the TSLS
method.19 The TSLS estimate is a weighted average of the
ratio estimates calculated using each genetic variant in
turn.20 If the genetic variants are uncorrelated (in linkage
equilibrium), then the causal effect can be estimated from
summarized data on the genetic associations with the ex-
posure and with the outcome as:21
XJ
j¼1
c^2j r
2
Yj b^j
XJ
j¼1
c^2j r
2
Yj
: (3)
where b^j ¼ C^ jc^ j is the ratio method estimate for variant j,
and rYj is the standard error in the regression of the out-
come on the jth genetic variant, assumed to be known.
This same weighted average formula is used in a fixed-
effect meta-analysis, where the IV-specific causal estimates
b^j are the study-specific estimates, and the weights are the
inverse-variance weights.22 This summarized estimate,
which we refer to as an inverse-variance weighted (IVW)
estimate, will differ slightly from the TSLS estimate in fi-
nite samples, as the correlation between independent gen-
etic variants will not exactly equal zero,23 but the two
estimates will be equal asymptotically (that is, they both
tend towards the same quantity as their sample sizes in-
crease towards infinity). However, an advantage of the
Figure 1. Illustrative diagram showing the standard instrumental vari-
able assumptions for genetic variant Gj (solid lines) with potential viola-
tions of the assumptions shown by dotted lines (which are marked with
a ‘cross’). The genetic effect on the exposure X is cj , the direct genetic
effect on the outcome Y is aj and the causal effect of the exposure X on
the outcome Y is b.
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IVW estimate is that it can be calculated from summarized
data, whereas the TSLS estimate requires individual-level
data. We assume for the remainder of the manuscript that
the genetic variants are uncorrelated in their distributions
(that is, knowledge of one does not help to predict the
value of any other), as typically in Mendelian randomiza-
tion one variant is taken from each gene region. Distantly
located variants are usually uncorrelated; correlations be-
tween variants that are physically close can be found using
an online tool such as [http://www.broadinstitute.org/mpg/
snap/ldsearchpw.php].
If genetic variant j is not a valid IV, in particular be-
cause it has a direct effect on the outcome (aj 6¼ 0), then we
have bj ¼ bþ ajcj . The ratio estimate based on genetic vari-
ant j in an infinite sample will equal the true causal effect b
plus an error term
aj
cj
. In the same way, the TSLS and IVW
estimates will tend towards:
bþ
XJ
j¼1
cjr
2
Yj aj
XJ
j¼1
c2j r
2
Yj
¼ bþ Biasða; cÞ:
This implies that the TSLS estimate is consistent when the
assumption IV3 is true and all the aj parameters are zero. It
is also consistent if the pleiotropic effects happen to cancel
out, such that the bias term is equal to zero.24 Although
this will not be universally plausible, we explore the condi-
tion that the correlation between the genetic associations
with the exposure (the cj parameters) and the direct effects
of the genetic variants on the outcome (the aj parameters)
is zero. We refer to the condition that the distributions of
these parameters are independent as InSIDE (Instrument
Strength Independent of Direct Effect). It can be viewed as
a weaker version of the exclusion restriction assumption.
This relaxation of the IV assumptions was recently investi-
gated by Kolesa´r et al.,25 although their work differs from
ours and is not presented within the context of Mendelian
randomization.
Illustrative example
Illustrative data on the associations of multiple genetic
variants with an exposure variable and with an outcome
variable for 15 variants are displayed as a scatter plot in
Figure 2. This is similar to a radial plot occasionally used
in meta-analysis to display multiple estimates of the same
quantity with a range of precisions.26 In this example, all
of the IVs are invalid, but the InSIDE condition holds. The
true causal effect is shown by the dotted line. The ratio es-
timates based on each genetic variant are the gradients of
the slopes from the origin to the data point for that variant.
The IVW estimate (shown by the solid red line) is the slope
of the best fitting line through the data points that also
passes through the origin. This is equal to the coefficient
from a weighted regression of the gene–outcome associ-
ation estimates (C^j) on the gene–exposure association esti-
mates (c^j) with the intercept constrained to zero, and
weighted by the inverse of the precision of the IV–outcome
coefficients (r2Yj ).
27 Here, all of the instruments are in-
valid, and so the slope of this line differs substantially from
the true causal effect.
Under the InSIDE assumption, the numerator of the
bias term of the ratio estimate for the jth genetic variant a^j
is independent of its denominator, c^j. This means that the
bias of the ratio estimate b^j ¼ C^ jc^ j is inversely proportional
to cj. Consequently, ratio estimates for stronger genetic
variants (ones with greater values of c^j), such as the variant
marked (i) in Figure 2, will be on average closer to the true
causal effect than those from weaker genetic variants, such
as the variant marked (ii).
The data can also be displayed visually by a funnel
plot.28 In the context of meta-analysis, this is a plot of a
measure of the precision of study estimates vs the estimates
themselves (see Figures 3 and 4). Asymmetry in the funnel
plot will occur if there is directional small study bias, as ex-
treme results from smaller studies are more likely to be
published. In the context of Mendelian randomization, we
plot the genetic associations with the exposure c^j against
the individual IV estimates b^j, as the genetic associations
with the exposure are related to the precision of the IV esti-
mates. We refer to asymmetry in this plot as ‘directional’
pleiotropy, meaning that the pleiotropic effects of genetic
variants are not balanced about the null.
Figure 2. Plot of the gene–outcome (C^) vs gene–exposure (c^) regression
coefficients for a fictional Mendelian randomization analysis with 15
genetic variants. The true slope is shown by a dotted line, the inverse-
variance weighted (IVW) estimate by a red line, and the MR-Egger re-
gression estimate by a blue line. Refer to text for explanation of points
(i) and (ii).
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We consider regression of the C^j coefficients on the c^j
coefficients where the intercept is not constrained to be
zero. We fit the linear model:
C^j ¼ b0E þ bEc^j: (4)
(We draw attention to the slight oddity in notation: the
C^jand c^j association estimates are the data in this model,
and b0E and bE are the coefficients in the regression model;
estimates of these coefficients are also denoted by hats –
b^0E and b^E.)
This model performs Egger regression, a special case of
the general method of meta-regression.11,15 Egger’s test for
small study bias in meta-analysis assesses whether the
intercept term b0E is different from zero. This will occur if
the estimates from small studies (in the case of Mendelian
randomization, estimates from weaker genetic variants)
are more skewed towards either high or low values com-
pared with estimates from large studies (stronger variants).
The estimated value of the intercept in Egger regression
b^0E can be interpreted as an estimate of the average pleio-
tropic effect across the genetic variants. An intercept term
that differs from zero is indicative of overall directional
pleiotropy.
It has been also asserted that b^E is a bias-reduced esti-
mate for the true causal effect.14 Under model (1), we have
the following equation for the slope coefficient from Egger
regression:
b^E ¼
cov ðC^; c^Þ
var ðc^Þ ¼ b^ þ
cov ða^; c^Þ
var ðc^Þ :
In the limit as both the sample size and the number of gen-
etic variants increase to infinity, the InSIDE condition
ensures that covða^; c^Þ!N!1 cov ða; cÞ!J!1 0 and therefore
b^E is a consistent estimate of the causal effect b. This is
illustrated by the solid blue line in Figure 2.
If genetic variants have different minor allele frequen-
cies (MAFs), then a better measure of instrument strength
can be constructed, as causal estimates from variants with
low minor allele frequencies will have low precision.
Provided that the genetic associations with the outcome
are all estimated on the same individuals, the MAF-correc-
tion factors will be proportional to the standard errors of
the gene–outcome associations rYj present in equation (3)
under the assumption that the variant is in Hardy–
Weinberg equilibrium, and so this correction is equivalent
to performing Egger regression as a weighted linear regres-
sion using the r2Yj as weights. The MAF-corrected weights
are the same as those used by the IVW method in formula
(3). If one uses the MAF-corrected weights within Egger
regression, the InSIDE assumption must be that they are in-
dependent of the direct effects on the outcome. In order to
distinguish our novel adaptation of Egger regression to
Mendelian randomization from its original context, we
will henceforth refer to its general application in this set-
ting as ‘MR-Egger regression’ and Egger’s test as the ‘MR-
Egger’ test.
Examples
To demonstrate this approach for the assessment of direc-
tional pleiotropy, we consider two illustrative examples of
Mendelian randomization using many genetic variants that
have been recently published. We use the available data on
genetic associations with the exposure and with the out-
come to construct a funnel plot and perform a visual in-
spection for asymmetry, as well as a formal statistical test
using MR-Egger regression. We comment on the differ-
ences between the IVW causal effect estimate from equa-
tion (3), which assumes that all the genetic variants are
valid IVs, and the MR-Egger estimate from equation (4),
which makes assumptions IV1, IV2 and the InSIDE
assumption.
Causal effect of height on lung function
In a primarily methodological investigation of weak instru-
ment bias, Davies et al.29 considered the causal effect of
height (standardized) on lung function (measured as forced
vital capacity, FVC, measured in ml) using 180 genetic
variants as IVs with data on 3631 participants from the
Avon Longitudinal Study of Parents and Children
(ALSPAC) cohort.30 These variants were originally identi-
fied in a genome-wide association study.31 The associ-
ations of the variants with height and with FVC are
displayed in a scatter plot in Figure 3 (left). The slope of
the line through the scatter plot is the IVW causal effect es-
timate using all the variants as IVs of 0.59 [95% confi-
dence interval (CI): 0.50, 0.67]. This is similar to the TSLS
estimate of 0.60 (95% CI: 0.52, 0.68) reported by Davies
et al. The causal estimates represent the increase in FVC
for a 1 standard deviation increase in height.
Figure 3 (right) shows a funnel plot of the MAF-cor-
rected genetic associations with the exposure against the
individual causal effect estimates for each variant. A visual
inspection of the funnel plot suggests that there is little
asymmetry present. Applying MR-Egger regression with
MAF-corrected weights to the summarized data yields an
intercept estimate -0.0009 with an associated P-value of
0.75. The bias-adjusted causal effect estimate from MR-
Egger regression is 0.60 (95% CI: 0.46, 0.75), a slight
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increase in magnitude and uncertainty compared with the
IVW and TSLS estimates. There was also no apparent het-
erogeneity in the IV estimates from each genetic variant in-
dividually, as evidenced by Cochran’s Q test (P¼ 0.99). In
the Web Appendix (available as Supplementary data at IJE
online) we show how the IVW and MR-Egger regression
methods were implemented on these data with just a single
line of computer code (using R and Stata). In summary,
there is no evidence that directional pleiotropy is an im-
portant factor for these data.
Causal effect of blood pressure on coronary
artery disease risk
Ehret et al.32 considered the causal effects of systolic blood
pressure (SBP) and diastolic blood pressure (DBP; both
measured in mmHg) on coronary artery disease (CAD) risk
using 29 uncorrelated genetic variants. We consider
data reported by Ehret et al. on genetic associations
with blood pressure in over 200 000 individuals based on
combined discovery and follow-up analysis, and data
used by Ehret et al. from the CARDIoGRAM consortium
Figure 3. Genetic associations with height and lung function from 180 variants measured in the ALSPAC dataset. Left: scatter plot of genetic associ-
ations with forced vital capacity (C^ j ) against associations with height (c^ j ), with causal estimate of height on lung function estimated by inverse-vari-
ance weighted method. Right: funnel plot of minor allele frequency corrected genetic associations with height (c^Cj ) against causal estimates based on
each genetic variant individually (b^ j ).
Figure 4. Genetic associations with blood pressure and coronary artery disease risk from 29 variants—funnel plots of minor allele frequency corrected
genetic associations with blood pressure (c^Cj ) against causal estimates of blood pressure on CAD based on each genetic variant individually (b^ j ). Left:
funnel plot for systolic blood pressure. Right: funnel plot for diastolic blood pressure. The inverse-variance weighted (IVW) and MR-Egger causal ef-
fect estimates are also shown.
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on genetic associations with coronary artery disease in
up to 22 233 cases and 64 762 controls of European des-
cent (data available online at [www.cardiogramplusc4d.
org]).33 The genetic associations with the exposure are
corrected for varying minor allele frequencies; the MAF-
corrected genetic associations are used in the figures and
analyses.
Figure A1 displays scatter plots for SBP and DBP sepa-
rately (available as Supplementary data at IJE online) and
equivalent funnel plots are shown in Figure 4. A certain
amount of asymmetry indicative of directional pleiotropy
is present in them. For example, for SBP, 10 out of the 13
weakest variants have estimates greater than the IVW
causal effect estimate.
For SBP, the IVW causal estimate of 0.054 (log odds
ratio per 1 mmHg change in blood pressure) is far from the
null (P¼4106, odds ratio 1.055). In contrast, the MR-
Egger test for the intercept gives a P-value of 0.21 and a
causal estimate closer to the null (bias-corrected estimate:
0.015, P¼0.64, odds ratio 1.015). For DBP, the IVW
causal estimate of 0.083 is again far from the null
(P¼ 1 105, odds ratio 1.087). The MR-Egger test gives
a P-value of 0.054 and a negative causal estimate (bias-
corrected estimate: 0.024, P¼ 0.67, odds ratio 0.976).
Additionally, Cochran’s Q test indicated strong evidence
of heterogeneity between IV estimates based on the indi-
vidual variants (P< 0.001 for both SBP and DBP). Given
the presence of apparent asymmetry in the funnel plots
(Figure 4), the application of the MR-Egger test casts some
doubt on the robustness of the original claims that these
data allow generation of Mendelian randomization style
analyses that provide strong support for the (well estab-
lished) notion that blood pressure is causally related to cor-
onary heart disease (CHD) risk.
Just as publication bias is not the only factor in a meta-
analysis that would lead to an intercept estimate away
from zero,11,13 it does not necessarily imply that the gen-
etic variants are pleiotropic in the Mendelian randomiza-
tion context. Furthermore, it would be very surprising if
blood pressure did not have some causal role in coronary
artery disease (CAD) risk. Indeed, the wide confidence
intervals for the causal effect of SBP and DBP on CAD risk
obtained from MR-Egger regression are consistent with de-
finitive analyses of the randomized trial evidence on the ef-
fectiveness of blood pressure-lowering treatments.34 It is
therefore interesting to speculate what other mechanisms
could be responsible for producing the asymmetry seen
here. One alternative explanation is that the weaker gen-
etic variants are more likely to be subject to the Beavis ef-
fect (also called ‘winner’s curse’).35 If genetic variants are
chosen due to their association with the exposure in the
dataset under analysis, then the association with the
exposure is likely to be overestimated, and the association
with the outcome could also then be overestimated due to
confounding. This is known to lead to bias in Mendelian
randomization estimates when there is overlap in the data-
sets used for estimating the genetic associations with the
exposure and with the outcome (as is the case here).36
However, genetic associations with SBP and DBP from the
replication analyses only were not reported in the original
study, limiting the possibility to distinguish whether the
asymmetry in the funnel plot is due to directional plei-
otropy or the winner’s curse.
Simulations
To further investigate the statistical properties of MR-
Egger regression under realistic conditions, we perform a
simulation study, generating artificial data with 25 genetic
variants used as instrumental variables. We generate data
in a two-sample Mendelian randomization setting, in
which data on the genetic associations with the exposure
and with the outcome are estimated in non-overlapping
sets of individuals. Furthermore, we allow ourselves to
make use of the summary data estimates only (e.g. the indi-
vidual estimates for c^j; C^j; andr
2
Yj; j ¼ 1; . . . ; 25). The
summarized data setting is increasingly common for
applied Mendelian randomization investigations, such as
the example of blood pressure and coronary artery disease
risk. The IVW estimator was therefore felt to be the most
natural implementation of the ‘standard’ approach to
Mendelian randomization that could also be applied in this
context, and so we chose this as our comparator. We ex-
pect its performance to closely mirror the two-sample two-
stage least squares (TS2SLS) method,37 a variant of TSLS
that can be applied to individual participant data in the
two-sample setting, given their asymptotic equivalence.
The simulations are repeated in the Web Appendix (avail-
able as Supplementary data at IJE online) in a one-sample
setting. In this case, we found that the performance of
standard one-sample TSLS and the IVW method were in-
deed highly similar.
We consider four scenarios for the pattern of plei-
otropy, and consider the bias and coverage properties of
the estimators with null and positive causal effects. The
scenarios considered are:
• no pleiotropy, InSIDE assumption trivially satisfied (all
the a parameters, representing the direct effects of gen-
etic variants on the outcome, are equal to zero);
• balanced pleiotropy, InSIDE assumption satisfied (a par-
ameters take positive and negative values);
• directional pleiotropy, InSIDE assumption satisfied (a
parameters take only positive values, but are generated
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independently from the c parameters, representing gen-
etic effects on the exposure);
• directional pleiotropy, InSIDE assumption not satisfied
(a parameters take positive values, and are correlated
with the genetic effects on the exposure).
A possible situation corresponding to scenario (d) is
that the pleiotropic effects of the genetic variants on the
outcome act via a confounder. Specifically, if a genetic
variant influences a confounder of the relationship be-
tween the exposure and outcome, then this will affect its
associations with both the exposure and the outcome, lead-
ing to the InSIDE assumption being violated. Funnel plots
illustrating data generated under each of these four scen-
arios for 50 genetic variants are provided in Figure 5. The
details of parameters used in the simulation study and to
produce Figure 5 are given in the Web Appendix (equiva-
lent scatter plots for Figure 5 are also shown in Web Figure
A2, available as Supplementary data at IJE online). We are
particularly interested in the coverage properties of the es-
timators with a null causal effect, and the power of estima-
tors with a positive causal effect, as salient findings from
Mendelian randomization investigations are not only the
magnitude of the causal effect—or indeed whether such
can be estimated—but also whether a causal effect is pre-
sent or absent.1,38
Results
Results from the simulation study are given in Table 1 for
10 000 simulated datasets. Each row of the table corresponds
Figure 5. Funnel plots of minor allele frequency corrected genetic associations with exposure (c^Cj ) against causal estimates based on each genetic
variant individually (b^ j ) for 50 IV estimates in four scenarios: (a) no pleiotropy; (b) balanced pleiotropy; (c) directional pleiotropy, InSIDE assumption
satisfied; and (d) directional pleiotropy, InSIDE assumption not satisfied. The inverse-variance weighted (IVW, red) and MR-Egger (blue) causal effect
estimates are also shown.
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Table 1. Performance of inverse-variance weighted and MR-Egger regression estimates in simulation study for two-sample
Mendelian randomization with a null (b¼0) and a positive (b¼0.05) causal effect. All tests are performed at 5% significance
level
Inverse-variance weighted MR-Egger regression
Mean F Mean estimate Power to detect Mean estimate Power of Power to detect
N statistic (mean SE) causal effect (mean SE) MR-Egger test causal effect
No causal effect: b¼0
Scenario (a) no pleiotropy, InSIDE satisfied
250 10.4 0.000 (0.022) 0.055 0.000 (0.047) 0.052 0.052
500 19.8 0.000 (0.015) 0.050 0.000 (0.035) 0.049 0.048
750 29.2 0.000 (0.013) 0.048 0.000 (0.030) 0.051 0.050
1000 38.6 0.000 (0.011) 0.049 0.000 (0.026) 0.048 0.050
Scenario (b) balanced pleiotropy, InSIDE satisfied
250 10.4 0.000 (0.024) 0.052 0.001 (0.051) 0.047 0.050
500 19.8 0.000 (0.018) 0.052 0.000 (0.042) 0.051 0.050
750 29.2 0.000 (0.016) 0.048 0.000 (0.037) 0.053 0.049
1000 38.6 0.000 (0.015) 0.052 0.000 (0.034) 0.047 0.047
Scenario (c) directional pleiotropy, InSIDE satisfied
250 10.4 0.034 (0.023) 0.293 0.010 (0.049) 0.089 0.055
500 19.9 0.036 (0.017) 0.530 0.005 (0.037) 0.142 0.055
750 29.2 0.036 (0.014) 0.689 0.004 (0.032) 0.195 0.054
1000 38.7 0.037 (0.013) 0.792 0.002 (0.029) 0.249 0.054
Scenario (d) directional pleiotropy, InSIDE violated
250 10.6 0.115 (0.026) 0.989 0.037 (0.057) 0.330 0.110
500 20.2 0.119 (0.021) 1.000 0.026 (0.047) 0.545 0.099
750 29.7 0.120 (0.019) 1.000 0.022 (0.043) 0.651 0.088
1000 39.2 0.122 (0.018) 1.000 0.021 (0.041) 0.727 0.086
Positive causal effect: b¼0.05
Scenario (a) no pleiotropy, InSIDE satisfied
250 10.4 0.046 (0.022) 0.498 0.039 (0.049) 0.056 0.121
500 19.8 0.048 (0.016) 0.808 0.042 (0.037) 0.054 0.190
750 29.2 0.049 (0.013) 0.929 0.044 (0.031) 0.055 0.274
1000 38.6 0.049 (0.012) 0.977 0.045 (0.027) 0.053 0.347
Scenario (b) balanced pleiotropy, InSIDE satisfied
250 10.4 0.046 (0.024) 0.439 0.039 (0.053) 0.051 0.109
500 19.8 0.048 (0.019) 0.675 0.042 (0.043) 0.054 0.155
750 29.2 0.049 (0.016) 0.810 0.044 (0.038) 0.055 0.199
1000 38.6 0.049 (0.015) 0.881 0.045 (0.035) 0.050 0.234
Scenario (c) directional pleiotropy, InSIDE satisfied
250 10.4 0.080 (0.024) 0.890 0.048 (0.051) 0.110 0.148
500 19.9 0.084 (0.018) 0.995 0.047 (0.039) 0.174 0.215
750 29.2 0.085 (0.015) 1.000 0.048 (0.034) 0.227 0.276
1000 38.7 0.085 (0.013) 1.000 0.047 (0.030) 0.278 0.321
Scenario (d) directional pleiotropy, InSIDE violated
250 10.6 0.161 (0.029) 1.000 0.074 (0.061) 0.359 0.226
500 20.2 0.167 (0.023) 1.000 0.066 (0.050) 0.562 0.261
750 29.7 0.169 (0.020) 1.000 0.065 (0.045) 0.661 0.290
1000 39.2 0.171 (0.019) 1.000 0.065 (0.042) 0.731 0.316
SE, standard error.
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to a particular simulation scenario and study size pairing. In
each case, the mean F statistic across the 25 variants is also
shown, in order to indicate the average instrument strength.
This is a marker of the effective sample size of each scenario.
The IVW and MR-Egger methods were implemented using
weighted linear regression, as described in the Web
Appendix (available as Supplementary data at IJE online).
Standard errors and P-values (from t-tests) were taken dir-
ectly from the regression output. All tests were two-sided
and performed at a nominal significance level of 5%.
We first discuss results when there is a null causal effect
of b¼ 0. In scenario (a) (no pleiotropy), both the IVW and
MR-Egger regression return unbiased estimates for the
causal effect, although mean standard errors from MR-
Egger regression are generally twice as large as those from
the IVW method. Rejection rates for the causal null hy-
pothesis are controlled at the nominal 5% level for both
methods. Additionally, rejection rates for the MR-Egger
test are well controlled. The results for scenario (b) (bal-
anced pleiotropy) are similar to (a) except that balanced
pleiotropy has the effect of increasing the standard errors
of the IVW and MR-Egger estimates by approximately
20% on average. Despite all instruments being invalid due
to pleiotropy, rejection rates for the MR-Egger test of dir-
ectional pleiotropy remain at 5%.
In scenario (c) (directional pleiotropy) the standard IVW
estimate exhibits a marked bias. As the sample size in-
creases, this bias becomes increasingly severe, and rejection
rates for the causal null hypothesis increase from 30% to
80%. By contrast MR-Egger regression yields approxi-
mately unbiased estimates for b and type I error rates of the
causal null hypothesis for the MR-Egger estimator remain
around the 5% level. As the sample size increases, the power
to detect directional pleiotropy rises modestly from 10% to
just under 30%. In scenario (d) (directional pleiotropy), the
InSIDE assumption does not hold. The pleiotropy due to a
direct effect of variant j on the outcome (aj) is augmented
with strong effect through a confounder of 2.5 times the
magnitude of aj. This is a violation of causal assumption
IV1, in addition to IV3. In this scenario, the standard IVW
estimate exhibits such strong bias that the power to reject
the causal null is essentially 1 for all sample sizes. MR-Egger
regression is more robust to this strong violation of IV1,
yielding estimates with a small amount of bias that decreases
with increasing sample size. Likewise, rejection rates of the
causal null hypothesis using MR-Egger regression are only
slightly inflated. The power of the MR-Egger test to detect
pleiotropy is also dramatically increased under scenario (d),
being over 70% when N¼1000.
We now examine estimator performance with a positive
causal effect of b¼ 0.05. In scenario (a) both methods exhibit
a small amount of bias towards the null in their estimates for
b for small sample sizes, with MR-Egger regression slightly
more affected. This is in line with bias from weak instru-
ments, which in a two-sample setting acts towards the null.39
As before, the IVW estimate is considerably more precise,
and consequently has greater power to reject the causal null
hypothesis. For the IVW approach, power increases from
50% to 98% as the sample size increases. For MR-Egger re-
gression, power increases from only 12% to 35%. Although
the power of the MR-Egger estimator to reject the causal null
is low, error rates for the MR-Egger test of directional plei-
otropy are still well controlled. The performance of both
methods in scenario (b) is similar to (a), except the power to
reject the causal null is reduced for both methods. In scen-
arios (c) and (d), the IVW estimate exhibits marked bias but
very high power to reject the causal null, whereas MR-Egger
regression yields approximately unbiased or minimally biased
estimates and lower power.
In a second simulation we investigate the performance
of the IVW method and MR-Egger regression under the
causal null b¼ 0 in scenario (c), with a fixed sample size of
N¼ 2000 but varying the number of genetic variants. The
results are shown in Table 2. The bias of the IVW estima-
tor reduces by just under 20% as the number of genetic
variants J increases from 3 (very strong) instruments to
150 (weaker) instruments. However, this coincides with a
reduction in the estimate’s standard error, so that its type I
error rate rises sharply from 12% to 100%. MR-Egger re-
gression returns approximately unbiased estimates for b
for all values of J. As J increases the power of the MR-
Egger test to detect directional pleiotropy increases from
around 5% to 95%. The type I error rate of MR-Egger re-
gression to detect a causal effect is well controlled for
J 50 variants, but for over 100 variants some type I error
inflation is apparent. In summary, MR-Egger regression
works well with large numbers of genetic variants (in the
sense that it has an increased power to detect pleiotropy),
as long as the variants are not too weak.
Discussion
In this paper we have proposed a simple sensitivity analysis
for Mendelian randomization investigations using large
numbers of genetic variants that may or may not have
pleiotropic effects on the outcome of interest. Egger’s test
is widely used as a tool for detecting small-study bias in
meta-analysis. Under the InSIDE assumption that the dir-
ect pleiotropic effects of the genetic variants on the out-
come are distributed independently of the genetic
associations with the exposure, MR-Egger regression pro-
vides a valid test of directional (unbalanced) pleiotropy,
and a valid test of the causal null hypothesis. Under this as-
sumption, the slope estimate from MR-Egger regression is
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a consistent estimate of the true causal effect. When there
are pleiotropic instruments but the InSIDE assumption is
not satisfied, MR-Egger regression does not give a consist-
ent estimate of causal effect, but remains a more robust
method of inference compared with standard approaches
which rely on the stronger assumption that there is no plei-
otropy. This renders it an important sensitivity analysis
tool in the Mendelian randomization context. In Box 1 we
re-state the critical assumptions required for the valid ap-
plication of MR-Egger regression and provide a step-by-
step guide to its application in practice.
Relation to existing literature
Several statistical methods have been proposed for consist-
ent estimation of causal effects when the IV assumptions
are not all satisfied. For example, Kang et al.40 propose
a scenario in which only half of the genetic variants are
required to be valid IVs. If infinite data were available,
the identity of the valid IVs would be clear, as they
would identify the same causal effect. Kang et al. provide
an estimation method based on lasso penalization41 which
not only gives consistent causal estimates in infinite sam-
ples, but also has reasonable finite sample properties.
Table 2. Performance of inverse-variance weighted and MR-Egger regression estimates ina simulation study for two-sample
Mendelian randomization with a null causal effect (b¼0) and a fixed sample size, and varying the number of genetic variants (J)
Inverse-variance weighted MR-Egger regression
J
Mean F
statistic
Mean estimate
(mean SE)
Power to detect
causal effect
Mean estimate
(mean SE)
Power of
MR-Egger test
Power to detect
causal effect
No causal effect: b¼0
Scenario (c) directional pleiotropy, InSIDE satisfied
3 407.0 0.042 (0.028) 0.127 0.003 (0.103) 0.059 0.054
5 295.0 0.039 (0.022) 0.248 0.000 (0.060) 0.085 0.050
10 172.0 0.038 (0.015) 0.580 0.001 (0.037) 0.166 0.051
15 121.0 0.037 (0.013) 0.780 0.000 (0.030) 0.248 0.048
20 93.6 0.037 (0.011) 0.894 0.001 (0.025) 0.329 0.055
30 64.4 0.037 (0.009) 0.980 0.001 (0.020) 0.475 0.052
50 39.8 0.036 (0.007) 1.000 0.002 (0.015) 0.667 0.058
100 20.7 0.035 (0.005) 1.000 0.005 (0.011) 0.877 0.082
150 14.2 0.035 (0.004) 1.000 0.007 (0.008) 0.944 0.150
Box 1. Summary of assumptions for application of MR-Egger regression
• We take summarized genetic association estimates with the exposure (c^1; . . . ; c^J ), with the outcome (C^1; . . . ; C^J ), and
standard errors of the genetic associations with the outcome (rY1; . . . ;rYJ ) for J genetic variants which are: (i) ro-
bustly associated with the exposure, (ii) uncorrelated with each other and (iii) in Hardy-Weinberg equilibrium. All vari-
ants must be orientated such that the genetic associations with the exposure have the same sign (that is, they must
all be positive or all negative).
• For the standard inverse-variance weighted method, we perform a weighted linear regression of the genetic associ-
ations with the outcome on the genetic associations with the exposure, weighting by the inverse-variance of the gen-
etic associations with the outcome (r2Yj ). In this regression model, the intercept is constrained to equal zero. This ana-
lysis assumes that all genetic variants are valid instrumental variables.
• For the proposed MR-Egger method, we perform the same weighted linear regression with the intercept uncon-
strained. The intercept represents the average pleiotropic effect across the genetic variants (the average direct effect
of a variant with the outcome). If the intercept differs from zero (the MR-Egger test), then there is evidence of direc-
tional pleiotropy. Under the assumption that the associations of the genetic variants with the exposure are independ-
ent of the direct effects of the genetic variants on the outcome (the InSIDE assumption), the slope coefficient from
the MR-Egger regression is a consistent estimate of the causal effect. This is a weaker assumption than the assump-
tion that all genetic variants are valid instrumental variables.The InSIDE assumption would be violated if the pleio-
tropic effects act via a confounder of the exposure—outcome association.
• R and Stata code to perform the inverse-variance weighted and MR-Egger methods is provided in the Web Appendix
(available as Supplementary data at IJE online).
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However, in contrast with the method proposed in this
paper, which allows all the genetic variants to be invalid
IVs, Kang et al. require at least half of the genetic variants
to be valid IVs. Otherwise, if causal estimates from the two
sets of valid and invalid genetic variants tended towards
different values, it would not be possible to distinguish
which of those values is the causal effect. A similar ap-
proach is simply to calculate the causal estimates using
each genetic variant individually, rank the estimates in
order of magnitude and take the median estimate.42 Again,
this is guaranteed to give a consistent causal estimate if at
least half of the genetic variants are valid IVs, although at
the cost of a considerable reduction in precision of the
causal estimate. Kolesa´r et al.25 also propose a consistent
causal estimator under the same conditions as considered
in this paper. This is based on a modified version of the
bias-corrected TSLS estimator, which is part of the wider
group of k-class estimators, a group that also includes the
TSLS, bias-corrected TSLS and limited information max-
imum likelihood estimators.43 Further theoretical work is
needed to compare the statistical properties of this estima-
tor with the MR-Egger estimator proposed in this paper.
As Mendelian randomization with multiple IVs can be
viewed as a meta-analysis of summarized genetic associ-
ation estimates, methods and diagnostic tools developed
for meta-analysis can also be used for Mendelian random-
ization. This is particularly relevant as summarized genetic
association estimates from large consortia are increasingly
becoming publicly available (such as those from the
CARDIoGRAM consortium used in this paper).44 It has
been shown that Mendelian randomization analyses based
on summarized data are as efficient as those based on indi-
vidual-level data.23 Other tools from the meta-analysis lit-
erature include methods for bias adjustment, such as the
trim-and-fill method,45 and the use of pseudo-data.46
Another diagnostic tool is a heterogeneity test, which tests
whether differences between estimates from different stud-
ies are compatible with chance variation.47 This can be
performed using Cochran’s Q statistic.44 The null hypoth-
esis is that the underlying association is the same in each
study. In the Mendelian randomization context, we can
test whether causal estimates from different genetic vari-
ants are compatible. Considerable heterogeneity would be
evidence that the genetic variants are estimating different
quantities, and would cast doubt on the IV assumptions
being valid for all the variants. In IV analysis more gener-
ally, a heterogeneity test is equivalent to an over-identifica-
tion test, often performed with individual-level data as part
of a TSLS analysis.48
Another problem with the use of many genetic variants
is that of weak instruments. With many IVs in a one-sam-
ple setting (genetic variants, exposure and outcome
measured in the same participants), IV estimates (particu-
larly those from the TSLS method) are biased in the direc-
tion of the observational association between the exposure
and the outcome.49 This bias depends on the strength of
the association of the IVs with the exposure, and is typic-
ally small if there is one IV50 or if the IVs are strongly asso-
ciated with the exposure, but the bias may be substantial
for Mendelian randomization in realistic settings.36 In a
two-sample setting, weak instrument bias is in the direc-
tion of the null, and hence is a less serious problem, as it
will not lead to false-positive findings.37,39 One solution
proposed for weak instrument bias is the use of allele
scores, whereby the number of exposure-increasing alleles
across multiple genetic variants is summed across individ-
uals.9 The total number of alleles (possibly weighted ac-
cording to their association with the exposure) is then used
as a single IV, rather than the genetic variants each being
used as separate IVs. Provided that the weights are not
taken from the data under analysis, this leads to estimates
that are less affected by weak instrument bias. However, if
results are solely given in terms of an allele score and not
in terms of the individual variants, then inconsistency of
causal estimates from different variants (either directional
pleiotropy or heterogeneity) may not be evident. Failure of
the MR-Egger test does not necessarily imply that the allele
score estimate will be biased; however, it strongly suggests
that bias may be an issue. It is therefore important not sim-
ply to report the associations of exposure and outcome
with the allele score, but also associations with the genetic
variants individually, such as in the scatter plot or funnel
plot representations shown in this paper.
Limitations of the proposed approach
Whereas the InSIDE assumption is plausible in some cases,
it will not be valid in all circumstances, particularly if the
pleiotropic effects of genetic variants act on confounders of
the exposure–outcome association. This is because the con-
founders will induce a correlation between the direct ef-
fects of the variants on the outcome and the genetic
associations with the exposure. This would occur, for ex-
ample, in the case of population stratification. Another im-
portant way this could occur is if a genetic variant in truth
affects an exposure causally upstream of the one under
investigation (for example, if the exposure of interest is
C-reactive protein but an included variant is associated
with body mass index). However, in simulation scenario
(d), where the pleiotropic effects through confounders
(violating InSIDE) were 2.5 times larger than the direct
pleiotropic effects (satisfying InSIDE), estimates from MR-
Egger regression were much less biased and rejection rates
of the causal null hypothesis were much closer to the
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nominal 5% rate than those from conventional IV meth-
ods. A related limitation is power—although the MR-
Egger regression estimator was more robust, power to de-
tect a causal effect was much reduced.
At present, we have not validated a universally reliable
method for determining standard errors of the MR-Egger
estimator when the causal effect is non-zero. Possible
approaches include bootstrapping in a one-sample setting,
or a hierarchical likelihood-based model that accounts for
uncertainty in the genetic associations used as data points
in the regression model. Other methods for giving valid in-
ferences in the context of a meta-analysis and small-study
bias have been discussed in the literature.14,15 The methods
described in this paper therefore provide a sensitivity ana-
lysis to assess robustness of the conclusions of a Mendelian
randomization investigation to potential bias from direc-
tional pleiotropy, and contribute to the overall evidence re-
garding the existence, direction and magnitude of the
causal effect. If the MR-Egger estimate differs substantially
from a conventional IV estimate, as in the example of
blood pressure and coronary artery disease risk, the causal
finding clearly requires additional interrogation. However,
confidence intervals for the causal effect should be inter-
preted with caution when far from the null, for the reasons
discussed.
In this article, we have assumed that genetic variants
are uncorrelated. If the variants are correlated, and the cor-
relations between variants are known, they can therefore
be used within generalized weighted linear regression
instead of weighted linear regression in either the IVW or
MR-Egger method, incorporating the correlations into the
weighting matrix. Further work is currently being under-
taken to explore this method.
One further limitation of this approach is the assump-
tion that the same causal effect is identified by multiple
IVs. This assumption is not unique to our approach, as it
is commonly made in IV analyses with multiple IVs. The
presence of ‘treatment effect heterogeneity’ is a complicat-
ing factor in causal analyses more generally, as it is not
clear how to interpret a causal effect estimate if its magni-
tude depends on the nature of the intervention on the
exposure. This is an important avenue for further
research.
Conclusion
In conclusion, the approaches of this paper should not be
interpreted as a pretext for conducting Mendelian random-
ization analyses with large numbers of genetic variants
without prior regard to the validity of the IV assumptions.
However, they provide simple graphical and statistical
methods that can detect some violations of the IV
assumptions, and can therefore can used as a sensitivity
analysis for assessing whether the effect estimation in a
Mendelian randomization analysis is influenced by direc-
tional pleiotropic effects of the genetic variants.
Supplementary Data
Supplementary data are available at IJE online.
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